SCO-240 is under clinical development by Scohia Pharma and currently in Phase I for Growth Hormone Deficiency.

"In people with progressive cognitive decline, the diagnosis of Alzheimer's disease requires a demonstration of amyloid and ...

Hormones do a lot throughout a person’s lifespan. Most people associate hormones with development and sex. Learn about their ...